| Type | Private |
|---|---|
| Industry | Health |
| Founded | 2014 |
| Founder |
|
| Headquarters | Oakland, CA |
| Website | www |
Eko Health Inc. (Eko) is an American healthcare technology company that develops medical devices, software, and clinical support AI to detect cardiovascular and pulmonary disease. [1]
Eko was founded in 2013 by Connor Landgraf, Jason Bellet, and Tyler Crouch. Landgraf was inspired to create Eko after seeing the limitations of traditional stethoscopes during his studies in biomedical engineering at the University of California, Berkeley and recruited his classmates Bellet and Crouch to join him. [2]
In 2015, Eko received FDA clearance for its first product, CORE, a digital attachment for traditional stethoscopes with a compatible smartphone application. [3] In 2017, Eko received FDA clearance for the DUO, a combined digital stethoscope ECG that could be used without a traditional stethoscope. [4] In 2018, Eko's low ejection fraction screening algorithm, developed with the Mayo Clinic, received a ‘Breakthrough Device’ designation from the FDA. [5]
In 2020, Eko announced $65 million in funding, [6] and a collaboration with 3M. [7] Eko raised an additional $30M in funding in 2022, [8] and received FDA clearance for its murmur analysis software. [9]
In 2023, Eko received FDA-clearance for the CORE500 digital stethoscope, which combines artificial intelligence (AI) software, high-fidelity audio, full-color display and 3-lead electrocardiogram (ECG). CORE500 offers compatibility with Eko’s Sensora platform, which uses artificial intelligence (AI) in cardiac disease detection. [10]
The stethoscope is a medical device for auscultation, or listening to internal sounds of an animal or human body. It typically has a small disc-shaped resonator that is placed against the skin, with either one or two tubes connected to two earpieces. A stethoscope can be used to listen to the sounds made by the heart, lungs or intestines, as well as blood flow in arteries and veins. In combination with a manual sphygmomanometer, it is commonly used when measuring blood pressure.
Palpitations are perceived abnormalities of the heartbeat characterized by awareness of cardiac muscle contractions in the chest, which is further characterized by the hard, fast and/or irregular beatings of the heart.
Medtronic plc is an American medical device company. The company's operational and executive headquarters are in Minneapolis, Minnesota, and its legal headquarters are in Ireland due to its acquisition of Irish-based Covidien in 2015. While it primarily operates in the United States, it operates in more than 150 countries and employs over 90,000 people. It develops and manufactures healthcare technologies and therapies.
A medical device is any device intended to be used for medical purposes. Significant potential for hazards are inherent when using a device for medical purposes and thus medical devices must be proved safe and effective with reasonable assurance before regulating governments allow marketing of the device in their country. As a general rule, as the associated risk of the device increases the amount of testing required to establish safety and efficacy also increases. Further, as associated risk increases the potential benefit to the patient must also increase.
Automated ECG interpretation is the use of artificial intelligence and pattern recognition software and knowledge bases to carry out automatically the interpretation, test reporting, and computer-aided diagnosis of electrocardiogram tracings obtained usually from a patient.
Withings is a French consumer electronics company headquartered in Issy-les-Moulineaux, France. It also has offices in Boston, Massachusetts, USA, and Hong Kong, and distributes its products worldwide. Withings is known for design and innovation in connected devices, such as the first Wi-Fi scale on the market, an FDA-cleared blood pressure monitor, a smart sleep system, and a line of automatic activity tracking watches. It also provides B2B solutions for healthcare providers and researchers.
Computer-aided auscultation (CAA), or computerized assisted auscultation, is a digital form of auscultation. It includes the recording, visualization, storage, analysis and sharing of digital recordings of heart or lung sounds. The recordings are obtained using an electronic stethoscope or similarly suitable recording device. Computer-aided auscultation is designed to assist health care professionals who perform auscultation as part of their diagnostic process. Commercial CAA products are usually classified as clinical decision support systems that support medical professionals in making a diagnosis. As such they are medical devices and require certification or approval from a competent authority.
Scanadu was a Silicon Valley-based company that developed new medical devices from 2011 to 2016. In June 2020, after relaunching under the name inui Health, it was acquired by the Israeli healthcare startup Healthy.io.
Michael David Abràmoff is a Dutch-American ophthalmologist, computer scientist and entrepreneur. He is the Robert C. Watzke Professor of Ophthalmology and Visual Sciences at the Roy J. and Lucille A. Carver College of Medicine at the University of Iowa. He is the Founder and Executive Chairman of Digital Diagnostics, of Iowa City, called by Wired Magazine "the bolder AI company", and which received the first FDA marketing authorization for an autonomous diagnostic AI system in any field of medicine.
Wireless ambulatory electrocardiography (ECG) is a type of ambulatory electrocardiography with recording devices that use wireless technology, such as Bluetooth and smartphones, for at-home cardiac monitoring (monitoring of heart rhythms). These devices are generally recommended to people who have been previously diagnosed with arrhythmias and want to have them monitored, or for those who have suspected arrhythmias and need to be monitored over an extended period of time in order to be diagnosed.
Qardio, Inc. is an American technology company that specializes in heart health monitoring products. It was founded by Marco Peluso and Rosario Iannella in early 2012.
Artificial intelligence in healthcare is an overarching term used to describe the use of machine-learning algorithms and software, or artificial intelligence (AI), to mimic human cognition in the analysis, presentation, and comprehension of complex medical and health care data, or to exceed human capabilities by providing new ways to diagnose, treat, or prevent disease. Specifically, AI is the ability of computer algorithms to approximate conclusions based solely on input data.
AliveCor is a medical device and AI company that develops ECG hardware and software compatible with consumer mobile devices to enable remote heart rhythm monitoring and detection of abnormal heart rhythms, or arrhythmias. AliveCor was founded in 2011 and is headquartered in Mountain View, California, the United States.
CardiacSense is a developer of a wearable technology for continuous cardiac arrhythmia detection and vital signs monitoring. CardiacSense is based in Caesarea, Israel.
Aidoc Medical is an Israeli technology company that develops computer-aided simple triage and notification systems. Aidoc has obtained FDA and CE mark approval for its stroke, pulmonary embolism, cervical fracture, intracranial hemorrhage, intra-abdominal free gas, and incidental pulmonary embolism algorithms.
The Artificial Intelligence of Things (AIoT) is the combination of Artificial intelligence (AI) technologies with the Internet of things (IoT) infrastructure to achieve more efficient IoT operations, improve human-machine interactions and enhance data management and analytics.
Empatica Inc. is an MIT Media Lab spinoff company born in Cambridge, Massachusetts, operating in Healthcare, providing AI-enabled tools to advance forecasting, monitoring, research, and treatment. Empatica produces medical-grade wearables, software and algorithms for the collection and interpretation of physiological data. Empatica's wearables, Embrace2 and E4, track physiological signals such as Heart Rate Variability, electrodermal activity, acceleration and movement, skin temperature, and autonomic arousal. Embrace2 has been cleared by the FDA as a seizure alerting solution for epilepsy patients with generalized tonic-clonic seizures. The E4 is used by researchers for real-time physiological data capture. The company is headquartered in Boston, MA with offices in Milan, Italy, and Seoul, South Korea.
A coronavirus breathalyzer is a diagnostic medical device enabling the user to test with 90% or greater accuracy the presence of severe acute respiratory syndrome coronavirus 2 in an exhaled breath. As of the first half of 2020, the idea of a practical coronavirus breathalyzer was concomitantly developed by unrelated research groups in Australia, Canada, Finland, Germany, Indonesia, Israel, Netherlands, Poland, Singapore, United Kingdom and USA.
BioSerenity is medtech company created in 2014 that develops ambulatory medical devices to help diagnose and monitor patients with chronic diseases such as epilepsy. The medical devices are composed of medical sensors, smart clothing, a smartphone app for Patient Reported Outcome, a web platform to perform data analysis through Medical Artificial Intelligence for detection of digital biomarkers. The company initially focused on Neurology, a domain in which it reported contributing to the diagnosis of 30 000 patients per year. It now also operates in Sleep Disorders and Cardiology. BioSerenity reported it provides pharmaceutical companies with solutions for companion diagnostics.
AEYE Health is an American-Israeli healthcare technology company which develops AI and computer-vision-powered algorithms to detect various medical conditions and markers from retinal images. AEYE Health's technology is categorized as autonomous AI, designed to replace medical professionals, as opposed to decision-support technologies which are designed to assist them.
